Follow The Filings

SUPN position history

The shares of Supernus Pharmaceuticals (SUPN) that Krensavage Asset Management LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2025 Q1: 431,986 shares, $14M, 7.8% of portfolio, New
  2. 2025 Q2: 472,376 shares, $15M, 7.9% of portfolio, Add +9.3%
  3. 2025 Q3: 363,479 shares, $17M, 7.4% of portfolio, Reduce −23.1%
  4. 2025 Q4: 313,499 shares, $16M, 5.5% of portfolio, Reduce −13.8%
  5. 2026 Q1: 280,681 shares, $15M, 5.7% of portfolio, Reduce −10.5%
  6. 2026 Q2: 280,681 shares, $13M, 5.0% of portfolio
  7. 2026 Q3: 350,681 shares, $15M, 5.7% of portfolio, Add +24.9%
Holdings date Value % of holdings Shares Filing date All 13F holders